JENNIFER SAMPANG: Open Payments
NPI 1396745899 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$47,979 in 73 payments from 7 companies in 2025. Trend: 2023 $96,954 · 2024 $48,369 · 2025 $47,979
Speaker / faculty: $40,178Travel & lodging: $3,184Honoraria: $2,600Food & beverage: $1,510Consulting: $395Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 34 | $28,434 |
| ACADIA Pharmaceuticals Inc | 18 | $13,344 |
| ABBVIE INC. | 16 | $3,505 |
| Axsome Therapeutics, Inc. | 1 | $2,600 |
| Alpha Cognition USA, Inc. | 2 | $50 |
| Almatica Pharma LLC | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: AUSTEDO XR, NUPLAZID, VRAYLAR, Auvelity, Zunveyl, LOREEV XR, INGREZZA.
Industry payments across KY — which companies pay providers there.
